首页 > 最新文献

中华预防医学杂志最新文献

英文 中文
[Analysis of virus gene subtypes and drug resistance monitoring results of newly reported HIV/AIDS population in Anhui Province from 2020 to 2023]. [2020-2023年安徽省新报告艾滋病人群病毒基因亚型及耐药性监测结果分析]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240308-00198
Y Z Qin, Y L Shen, A W Liu, J J Wu, L F Miu, Q Fang, C X Shuai, L Jin

Objective: To investigate the genetic subtypes and drug resistance monitoring of newly reported human immunodeficiency virus (HIV) infection/AIDS virus in Anhui Province from 2020 to 2023. Methods: An observational design study was used to collect blood samples from patients diagnosed with HIV/AIDS in the AIDS Prevention and Control Department of Anhui Provincial Center for Disease Control and Prevention from January 2020 to December 2023.The HIV-1 pol gene was amplified by reverse transcription-nested PCR, and the genetic subtypes were identified by phylogenetic tree analysis using MEGA 7.0 software. The mutation sites of drug resistance were analyzed by the online software tool of Stanford University's HIV Drug resistance database. The influencing factors of drug resistance before treatment were analyzed by multivariate logistic analysis. Results: A total of 335 plasma samples were collected, and 332 HIV-1 pol gene sequences were obtained successfully. The main gene subtypes were CRF01-AE, accounting for 35.55% (118/332), followed by CRF07-BC, B and B+C types [29.22% (97/332), 11.74% (39/332), 9.93% (33/332)]. The total drug resistance rate before treatment was 30.12%(32/100), and the drug resistance rate of protease inhibitor (PIs) in HIV-1 was 6.33% (21/332). The drug resistance rate of nucleoside reverse transcriptase inhibitors (NRTI) before treatment was 6.33% (21/332). The drug resistance rate of non-nucleoside reverse transcriptase inhibitors (NNRTI) before treatment was 17.47% (58/332).The comparison of drug resistance rate of different drug types showed statistical significance (χ2=30.435, P<0.05).Among the 100 cases of drug resistance, the main mutation point of HIV-1 protease inhibitor was Q58E (21.00%), and the main mutation point of nucleoside reverse transcriptase inhibitor was M184V/I (6.00%). Non-nucleoside reverse transcriptase inhibitor resistance mutation points mainly K103N (22.00%).There were statistically significant differences in the starting time of antiviral therapy, the number of CD4+T cells at baseline and the drug resistance rate of gene subtypes (the chi-square values are respectively 24.152, 32.516, 11.652, P<0.05).Multivariate logistic analysis showed that the baseline CD4+T cell count was <200/μl, subtype B, subtype B+C, CRF01-AE subtype, CRF55-01B subtype and 01-BC subtype was the influential factor of drug resistance before treatment (the chi-square values are respectively 4.577, 8.202, 4.416, 5.206, 7.603 and 4.804, P<0.05). Conclusion: The newly reported HIV/AIDS population in Anhui Province from 2020 to 2023 has a variety of viral gene subtypes, and NNRTIs are the main types of drug resistance gene mutations before treatment. Attention should be paid to the number of baseline CD4+T cells, the duration of antiviral treatment, and the distribution of gene subtypes to reduce the drug resistance of HIV/AIDS

目的调查 2020 年至 2023 年安徽省新报告的人类免疫缺陷病毒(HIV)感染/艾滋病病毒的基因亚型和耐药性监测情况。方法采用观察性设计研究方法,采集2020年1月至2023年12月安徽省疾病预防控制中心艾滋病预防控制所确诊的HIV/AIDS患者血样,通过反转录巢式PCR扩增HIV-1 pol基因,采用MEGA 7.0软件进行系统发生树分析,确定基因亚型。利用斯坦福大学艾滋病毒耐药性数据库的在线软件工具分析了耐药性的突变位点。治疗前耐药性的影响因素采用多变量逻辑分析法进行分析。结果共采集 335 份血浆样本,成功获得 332 个 HIV-1 pol 基因序列。主要基因亚型为 CRF01-AE,占 35.55%(118/332),其次为 CRF07-BC、B 和 B+C 型[29.22%(97/332)、11.74%(39/332)、9.93%(33/332)]。治疗前的总耐药率为 30.12%(32/100),HIV-1 对蛋白酶抑制剂(PIs)的耐药率为 6.33%(21/332)。治疗前核苷类逆转录酶抑制剂(NRTI)的耐药率为 6.33%(21/332)。不同药物类型的耐药率比较具有统计学意义(χ2=30.435,基线 P+T 细胞和基因亚型的耐药率(chi-square 值分别为 24.152、32.516、11.652,P+T 细胞计数为 PC):2020-2023年安徽省新报告HIV/AIDS人群病毒基因亚型多样,NNRTIs是治疗前耐药基因突变的主要类型。治疗前应注意基线CD4+T细胞数量、抗病毒治疗时间、基因亚型分布等,以减少HIV/AIDS患者耐药。
{"title":"[Analysis of virus gene subtypes and drug resistance monitoring results of newly reported HIV/AIDS population in Anhui Province from 2020 to 2023].","authors":"Y Z Qin, Y L Shen, A W Liu, J J Wu, L F Miu, Q Fang, C X Shuai, L Jin","doi":"10.3760/cma.j.cn112150-20240308-00198","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240308-00198","url":null,"abstract":"<p><p><b>Objective:</b> To investigate the genetic subtypes and drug resistance monitoring of newly reported human immunodeficiency virus (HIV) infection/AIDS virus in Anhui Province from 2020 to 2023. <b>Methods:</b> An observational design study was used to collect blood samples from patients diagnosed with HIV/AIDS in the AIDS Prevention and Control Department of Anhui Provincial Center for Disease Control and Prevention from January 2020 to December 2023.The HIV-1 pol gene was amplified by reverse transcription-nested PCR, and the genetic subtypes were identified by phylogenetic tree analysis using MEGA 7.0 software. The mutation sites of drug resistance were analyzed by the online software tool of Stanford University's HIV Drug resistance database. The influencing factors of drug resistance before treatment were analyzed by multivariate logistic analysis. <b>Results:</b> A total of 335 plasma samples were collected, and 332 HIV-1 pol gene sequences were obtained successfully. The main gene subtypes were CRF01-AE, accounting for 35.55% (118/332), followed by CRF07-BC, B and B+C types [29.22% (97/332), 11.74% (39/332), 9.93% (33/332)]. The total drug resistance rate before treatment was 30.12%(32/100), and the drug resistance rate of protease inhibitor (PIs) in HIV-1 was 6.33% (21/332). The drug resistance rate of nucleoside reverse transcriptase inhibitors (NRTI) before treatment was 6.33% (21/332). The drug resistance rate of non-nucleoside reverse transcriptase inhibitors (NNRTI) before treatment was 17.47% (58/332).The comparison of drug resistance rate of different drug types showed statistical significance (<i>χ</i><sup>2</sup>=30.435, <i>P</i><0.05).Among the 100 cases of drug resistance, the main mutation point of HIV-1 protease inhibitor was Q58E (21.00%), and the main mutation point of nucleoside reverse transcriptase inhibitor was M184V/I (6.00%). Non-nucleoside reverse transcriptase inhibitor resistance mutation points mainly K103N (22.00%).There were statistically significant differences in the starting time of antiviral therapy, the number of CD4<sup>+</sup>T cells at baseline and the drug resistance rate of gene subtypes (the chi-square values are respectively 24.152, 32.516, 11.652, <i>P</i><0.05).Multivariate logistic analysis showed that the baseline CD4<sup>+</sup>T cell count was <200/μl, subtype B, subtype B+C, CRF01-AE subtype, CRF55-01B subtype and 01-BC subtype was the influential factor of drug resistance before treatment (the chi-square values are respectively 4.577, 8.202, 4.416, 5.206, 7.603 and 4.804, <i>P</i><0.05). <b>Conclusion:</b> The newly reported HIV/AIDS population in Anhui Province from 2020 to 2023 has a variety of viral gene subtypes, and NNRTIs are the main types of drug resistance gene mutations before treatment. Attention should be paid to the number of baseline CD4<sup>+</sup>T cells, the duration of antiviral treatment, and the distribution of gene subtypes to reduce the drug resistance of HIV/AIDS","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Knowledge, attitude and practices of adult vaccine among the staff of vaccination units in Shandong Province]. [山东省接种单位工作人员对成人疫苗的认识、态度和实践]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240305-00188
S L Hu, Y Yu, W Y Zhang, Y J Zhang, R P Li, A Q Xu, Z H Yang

In order to understand the knowledge, attitude and practice (KAP) of vaccination against influenza, pneumonia, human papillomavirus (HPV), herpes zoster (HZ), COVID-19, and hepatitis B among staff of vaccination units in Shandong Province, a sample survey was conducted among 797 staffs of adult vaccination units in 12 counties (cities and districts) of Shandong Province from August to September 2022. The results showed that the respondents had the highest total score of knowledge and attitude for the COVID-19 vaccine, with the M (Q1, Q3) of 23 (20, 25) and 10 (10, 10), respectively, and had the lowest score of knowledge and attitude for the herpes zoster vaccine, with the M (Q1, Q3) of 19 (15, 22) and 8 (8, 10), respectively. The vaccine-related knowledge point"vaccine applicable population"had the highest score, with the M (Q1,Q3) of 26 (23, 30). The "contraindications/adverse reactions" and "adverse reaction management" had the lowest score, with the M (Q1, Q3) of 24 (20, 29) and 24 (20, 28), respectively. About 89.71% of respondents received one adult vaccine within two years at least. The principal driver for vaccination of 53.58% of recipients was their understanding of vaccines, which was"it was necessary to receive the vaccine". About 66.00% of respondents who had not received any adult vaccine in the past two years had insufficient awareness of the necessity of vaccination and believed that they were in good health and did not need to receive it. In summary, the staff of adult vaccination units in Shandong Province have a poor understanding of the herpes zoster vaccine in terms of vaccines and a relatively poor understanding of"contraindications/adverse reaction and management"in adult vaccination knowledge points.

为了解山东省预防接种单位工作人员对流感、肺炎、人乳头瘤病毒(HPV)、带状疱疹(HZ)、COVID-19和乙肝疫苗接种的知识、态度和实践(KAP)情况,我们于2022年8月至9月对山东省12个县(市、区)成人预防接种单位的797名工作人员进行了抽样调查。结果显示,被调查者对COVID-19疫苗的知识和态度总分最高,M(Q1,Q3)分别为23(20,25)和10(10,10);对带状疱疹疫苗的知识和态度总分最低,M(Q1,Q3)分别为19(15,22)和8(8,10)。疫苗相关知识点 "疫苗适用人群 "得分最高,M(Q1,Q3)为 26(23,30)。禁忌症/不良反应 "和 "不良反应处理 "得分最低,M(Q1,Q3)分别为 24(20,29)和 24(20,28)。约 89.71% 的受访者至少在两年内接种过一次成人疫苗。53.58%的受访者接种疫苗的主要原因是他们对疫苗的理解,即 "有必要接种疫苗"。约 66.00%的受访者在过去两年中没有接种过任何成人疫苗,他们对接种疫苗的必要性认识不足,认为自己身体健康,不需要接种疫苗。综上所述,山东省成人预防接种单位的工作人员对带状疱疹疫苗在疫苗方面的了解较少,对成人预防接种知识点中 "禁忌症/不良反应及处理 "的了解相对较少。
{"title":"[Knowledge, attitude and practices of adult vaccine among the staff of vaccination units in Shandong Province].","authors":"S L Hu, Y Yu, W Y Zhang, Y J Zhang, R P Li, A Q Xu, Z H Yang","doi":"10.3760/cma.j.cn112150-20240305-00188","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240305-00188","url":null,"abstract":"<p><p>In order to understand the knowledge, attitude and practice (KAP) of vaccination against influenza, pneumonia, human papillomavirus (HPV), herpes zoster (HZ), COVID-19, and hepatitis B among staff of vaccination units in Shandong Province, a sample survey was conducted among 797 staffs of adult vaccination units in 12 counties (cities and districts) of Shandong Province from August to September 2022. The results showed that the respondents had the highest total score of knowledge and attitude for the COVID-19 vaccine, with the <i>M</i> (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>) of 23 (20, 25) and 10 (10, 10), respectively, and had the lowest score of knowledge and attitude for the herpes zoster vaccine, with the <i>M</i> (<i>Q</i><sub>1</sub>, <i>Q</i><sub>3</sub>) of 19 (15, 22) and 8 (8, 10), respectively. The vaccine-related knowledge point\"vaccine applicable population\"had the highest score, with the <i>M (Q</i><sub>1</sub>,<i>Q</i><sub>3</sub><i>)</i> of 26 (23, 30). The \"contraindications/adverse reactions\" and \"adverse reaction management\" had the lowest score, with the <i>M (Q</i><sub>1</sub>, <i>Q</i><sub>3</sub><i>)</i> of 24 (20, 29) and 24 (20, 28), respectively. About 89.71% of respondents received one adult vaccine within two years at least. The principal driver for vaccination of 53.58% of recipients was their understanding of vaccines, which was\"it was necessary to receive the vaccine\". About 66.00% of respondents who had not received any adult vaccine in the past two years had insufficient awareness of the necessity of vaccination and believed that they were in good health and did not need to receive it. In summary, the staff of adult vaccination units in Shandong Province have a poor understanding of the herpes zoster vaccine in terms of vaccines and a relatively poor understanding of\"contraindications/adverse reaction and management\"in adult vaccination knowledge points.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Distribution and antibiotic resistance analysis of Gram positive cocci in bloodstream infections in a hospital in Inner Mongolia]. [内蒙古某医院血流感染中革兰氏阳性球菌的分布及抗生素耐药性分析]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231120-00354
L L Tian, B B Xing, Y M Zhang, J P Zhao

To investigate the strain composition and drug resistance characteristics of G+(Gram positive cocci) cocci causing bloodstream infections in the People's Hospital of Inner Mongolia Autonomous Region in recent years and provide a basis for the empirical and rational use of drugs for the prevention and treatment of bloodstream infections caused by G+cocci. The strain composition and drug-resistant characteristics of G+cocci isolated from positive blood culture specimens sent to various departments of the Inner Mongolia Autonomous Region People's Hospital from January 2015 to December 2022 were retrospectively analyzed, and the higher detection rates of Staphylococcus hominis and Staphylococcus epidermidis, Enterococcus faecium and Enterococcus faecalis, and methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) were examined. MRSA and methicillin-sensitive Staphylococcus aureus (MSSA) were comparatively analyzed for resistance. The resistance data were analyzed by Whonet 5.6 statistical software, the significance of difference was analyzed by SPSS 22.0 software, and the resistance rate was compared by χ2 test. The results showed that 1 209 strains of G+cocci, in terms of the composition ratio, from high to low, were mainly human staphylococci (32.5%,393/1 209), Staphylococcus epidermidis (27.8%, 336/1 209), Staphylococcus aureus (14.9%,180/1 209) and Enterococcus faecalis (10.6%, 128/1 209). Among them, the detection rate of methicillin-resistant Staphylococcus aureus (MRSA) (42.8%, 77/180) was lower than that of methicillin-resistant coagulase-negative staphylococcus (MRCNS) (71.5%, 608/850); and among enterococci, the detection rate of Enterococcus faecalis (71.5%, 128/179) was much higher than that of Enterococcus faecalis (28.5%, 51/179). For drug resistance, the resistance rate to five commonly used antimicrobial drugs, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin and tetracycline, was higher in Staphylococcus hominis than in Staphylococcus epidermidis (χ2=7.152-64.080, P<0.05); however, for the aminoglycoside antimicrobial drug gentamicin, the rate of resistance in Staphylococcus humanus was lower than in Staphylococcus epidermidis, and the difference was statistically significant (χ2=11.895, P<0.05); no strains resistant to linezolid and vancomycin were found in both. Comparison of the resistance rates to seven antimicrobial drugs, gentamicin, rifampicin, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin and tetracycline, was significantly higher in MRSA than in MSSA (χ2=6.169-56.941, P<0.05); however, the resistance rate to cotrimoxazole, MRSA (15.6%, 12/77) was significantly lower than that of MSSA (35.3%, 36/102), and the difference was statistically significant (χ2=5.155, P<0.05); MRSA and MSSA resistant to

摘要】 目的 探讨近年来内蒙古自治区人民医院引起血流感染的G+(革兰阳性球菌)球菌的菌株组成及耐药特点,为防治G+球菌引起的血流感染的经验性合理用药提供依据。回顾性分析了2015年1月至2022年12月送往内蒙古自治区人民医院各科室血液培养阳性标本中分离出的G+球菌的菌株组成和耐药特征、并考察了人葡萄球菌和表皮葡萄球菌、粪肠球菌和粪肠球菌、耐甲氧西林金黄色葡萄球菌(MRSA)和甲氧西林敏感金黄色葡萄球菌(MSSA)的较高检出率。对 MRSA 和对甲氧西林敏感的金黄色葡萄球菌(MSSA)的耐药性进行了比较分析。耐药性数据采用 Whonet 5.6 统计软件进行分析,差异显著性采用 SPSS 22.0 软件进行分析,耐药率比较采用 χ2 检验。结果表明,1 209 株 G+occi 菌株中,从构成比来看,由高到低主要为人葡萄球菌(32.5%,393/1 209)、表皮葡萄球菌(27.8%,336/1 209)、金黄色葡萄球菌(14.9%,180/1 209)和粪肠球菌(10.6%,128/1 209)。其中,耐甲氧西林金黄色葡萄球菌(MRSA)的检出率(42.8%,77/180)低于耐甲氧西林凝固酶阴性葡萄球菌(MRCNS)的检出率(71.5%,608/850);在肠球菌中,粪肠球菌的检出率(71.5%,128/179)远高于粪肠球菌(28.5%,51/179)。耐药性方面,同种葡萄球菌对环丙沙星、左氧氟沙星、莫西沙星、克林霉素和四环素五种常用抗菌药物的耐药率高于表皮葡萄球菌(χ2=7.152-64.080,Pχ2=11.895,P0.05);两者均未发现对利奈唑胺和万古霉素耐药的菌株。比较对庆大霉素、利福平、环丙沙星、左氧氟沙星、莫西沙星、克林霉素和四环素7种抗菌药物的耐药率,MRSA明显高于MSSA(χ2=6.169-56.941,Pχ2=5.155,P0.05);未发现对利奈唑胺和万古霉素耐药的MRSA和MSSA。粪肠球菌对青霉素G和氨苄西林的耐药率远高于粪肠球菌,差异有统计学意义(χ2=22.965,从血培养物中分离出的P+球菌为临床经验性合理用药提供依据,有效预防和降低G+球菌引起的血流感染发生率。
{"title":"[Distribution and antibiotic resistance analysis of Gram positive cocci in bloodstream infections in a hospital in Inner Mongolia].","authors":"L L Tian, B B Xing, Y M Zhang, J P Zhao","doi":"10.3760/cma.j.cn112150-20231120-00354","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231120-00354","url":null,"abstract":"<p><p>To investigate the strain composition and drug resistance characteristics of G<sup>+</sup>(Gram positive cocci) cocci causing bloodstream infections in the People's Hospital of Inner Mongolia Autonomous Region in recent years and provide a basis for the empirical and rational use of drugs for the prevention and treatment of bloodstream infections caused by G<sup>+</sup>cocci. The strain composition and drug-resistant characteristics of G<sup>+</sup>cocci isolated from positive blood culture specimens sent to various departments of the Inner Mongolia Autonomous Region People's Hospital from January 2015 to December 2022 were retrospectively analyzed, and the higher detection rates of Staphylococcus hominis and Staphylococcus epidermidis, Enterococcus faecium and Enterococcus faecalis, and methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-sensitive Staphylococcus aureus (MSSA) were examined. MRSA and methicillin-sensitive Staphylococcus aureus (MSSA) were comparatively analyzed for resistance. The resistance data were analyzed by Whonet 5.6 statistical software, the significance of difference was analyzed by SPSS 22.0 software, and the resistance rate was compared by <i>χ</i><sup>2</sup> test. The results showed that 1 209 strains of G<sup>+</sup>cocci, in terms of the composition ratio, from high to low, were mainly human staphylococci (32.5%,393/1 209), Staphylococcus epidermidis (27.8%, 336/1 209), Staphylococcus aureus (14.9%,180/1 209) and Enterococcus faecalis (10.6%, 128/1 209). Among them, the detection rate of methicillin-resistant Staphylococcus aureus (MRSA) (42.8%, 77/180) was lower than that of methicillin-resistant coagulase-negative staphylococcus (MRCNS) (71.5%, 608/850); and among enterococci, the detection rate of Enterococcus faecalis (71.5%, 128/179) was much higher than that of Enterococcus faecalis (28.5%, 51/179). For drug resistance, the resistance rate to five commonly used antimicrobial drugs, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin and tetracycline, was higher in Staphylococcus hominis than in Staphylococcus epidermidis (<i>χ</i><sup>2</sup>=7.152-64.080, <i>P</i><0.05); however, for the aminoglycoside antimicrobial drug gentamicin, the rate of resistance in Staphylococcus humanus was lower than in Staphylococcus epidermidis, and the difference was statistically significant (<i>χ</i><sup>2</sup>=11.895, <i>P<</i>0.05); no strains resistant to linezolid and vancomycin were found in both. Comparison of the resistance rates to seven antimicrobial drugs, gentamicin, rifampicin, ciprofloxacin, levofloxacin, moxifloxacin, clindamycin and tetracycline, was significantly higher in MRSA than in MSSA (<i>χ</i><sup>2</sup>=6.169-56.941, <i>P</i><0.05); however, the resistance rate to cotrimoxazole, MRSA (15.6%, 12/77) was significantly lower than that of MSSA (35.3%, 36/102), and the difference was statistically significant (<i>χ</i><sup>2</sup>=5.155, <i>P<</i>0.05); MRSA and MSSA resistant to ","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Prediction of the clinical supply of blood components in Xi'an City from 2023 to 2025]. [2023-2025年西安市血液成分临床供应预测]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231226-00496
L H Zhang, J Wang, B Yao, X Y Chu, Z D Sun, C F Ma

Objective: To construct a prediction model for the clinical supply of blood components in Xi'an City from 2023 to 2025. Methods: Based on the blood supply data of the Blood Management Information System of Shaanxi Provincial Blood Center from January 2013 to December 2022, a gray prediction model and an exponential curve fitting model were used to construct the prediction model, and the optimal prediction model was determined according to the error parameters of the relevant indicators of the model. The supply of blood components in Xi'an from 2023 to 2025 was predicted. Results: The fitting equations of the exponential curve fitting model to predict the supply of suspended red blood cells, platelets and cryoprecipitate in Xi'an were, x(1)t+1)=1.16e0.04tx(1)t+1)=1.04e0.12t and x(1)t+1)=1.01e1.10t, respectively. The mean absolute errors (mean relative errors) of the exponential curve fitting model in predicting the supply of suspended red blood cells, platelets and cryoprecipitate in Xi'an were 10 488.7 (0.05%), 2 114.9 (0.08%) and 3 089.6 (0.07%), respectively, which were lower than those of the gray prediction model, about 10 488.7 (3.44%), 2 152.78 (8.20%) and 3 441.35 (7.92%), respectively. The exponential curve fitting model predicted that the clinical supply of blood components in Xi'an would increase year by year from 2023 to 2025, and the clinical supply of suspended red blood cells, platelets, and cryoprecipitate in Xi'an would increase to 409 467 U, 69 818 therapeutic volume and 94 724 U, respectively by 2025. Conclusion: The exponential curve fitting model can make a good prediction of the clinical supply of blood components in Xi'an City.

目的构建 2023-2025 年西安市血液成分临床供应预测模型。方法:根据陕西省血液中心 2013 年 1 月至 2025 年血液管理信息系统的血液供应数据,建立西安市 2023 年至 2025 年血液成分临床供应预测模型:根据陕西省血液中心血液管理信息系统2013年1月至2022年12月的血液供应数据,采用灰色预测模型和指数曲线拟合模型构建预测模型,并根据模型相关指标的误差参数确定最优预测模型。预测了 2023 年至 2025 年西安市血液成分供应量。预测结果预测西安市悬浮红细胞、血小板和低温沉淀供应量的指数曲线拟合模型的拟合方程为:x(1)(t+1)=1.16e0.04t,x(1)(t+1)=1.04e0.12t,x(1)(t+1)=1.01e1.10t。指数曲线拟合模型预测西安市悬浮红细胞、血小板和低温沉淀供应量的平均绝对误差(平均相对误差)分别为10 488.7(0.05%)、2 114.9(0.08%)和3 089.6(0.07%),分别低于灰色预测模型的10 488.7(3.44%)、2 152.78(8.20%)和3 441.35(7.92%)。指数曲线拟合模型预测西安市血液成分临床供应量从 2023 年到 2025 年将逐年增加,到 2025 年西安市悬浮红细胞、血小板和低温沉淀的临床供应量将分别增加到 409 467 U、69 818 治疗量和 94 724 U。结论指数曲线拟合模型可以很好地预测西安市血液成分的临床供应量。
{"title":"[Prediction of the clinical supply of blood components in Xi'an City from 2023 to 2025].","authors":"L H Zhang, J Wang, B Yao, X Y Chu, Z D Sun, C F Ma","doi":"10.3760/cma.j.cn112150-20231226-00496","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231226-00496","url":null,"abstract":"<p><p><b>Objective:</b> To construct a prediction model for the clinical supply of blood components in Xi'an City from 2023 to 2025. <b>Methods:</b> Based on the blood supply data of the Blood Management Information System of Shaanxi Provincial Blood Center from January 2013 to December 2022, a gray prediction model and an exponential curve fitting model were used to construct the prediction model, and the optimal prediction model was determined according to the error parameters of the relevant indicators of the model. The supply of blood components in Xi'an from 2023 to 2025 was predicted. <b>Results:</b> The fitting equations of the exponential curve fitting model to predict the supply of suspended red blood cells, platelets and cryoprecipitate in Xi'an were, <i>x</i><sup>(1)</sup>(<i>t</i>+1)=1.16e<sup>0.04</sup><i><sup>t</sup></i>,<i>x</i><sup>(1)</sup>(<i>t</i>+1)=1.04e<sup>0.12</sup><i><sup>t</sup></i> and <i>x</i><sup>(1)</sup>(<i>t</i>+1)=1.01e<sup>1.10</sup><i><sup>t</sup></i>, respectively. The mean absolute errors (mean relative errors) of the exponential curve fitting model in predicting the supply of suspended red blood cells, platelets and cryoprecipitate in Xi'an were 10 488.7 (0.05%), 2 114.9 (0.08%) and 3 089.6 (0.07%), respectively, which were lower than those of the gray prediction model, about 10 488.7 (3.44%), 2 152.78 (8.20%) and 3 441.35 (7.92%), respectively. The exponential curve fitting model predicted that the clinical supply of blood components in Xi'an would increase year by year from 2023 to 2025, and the clinical supply of suspended red blood cells, platelets, and cryoprecipitate in Xi'an would increase to 409 467 U, 69 818 therapeutic volume and 94 724 U, respectively by 2025. <b>Conclusion:</b> The exponential curve fitting model can make a good prediction of the clinical supply of blood components in Xi'an City.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983411","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of ultrasensitive single molecule immunoassay technology in clinical biomarker detection]. [超灵敏单分子免疫测定技术在临床生物标记物检测中的应用]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20231212-00431
W C Jiang, G J Zhang

Single-molecule immunoassay technology represents an ultrasensitive immunoassay method that enables the resolution and detection of individual biomolecules at the nanoscale. This article highlights various representative techniques and clinical applications of single-molecule immunoassay technology, while also discussing the current challenges and future development directions. Through multiple optimizations at both the technical and commercial levels, single-molecule immunoassay technology exhibits unique advantages in real-time detection, disease diagnosis and treatment, and medical research. This technology is poised to contribute to the advancement of precision medicine by integrating individualized detection methods into clinical practice.

单分子免疫测定技术是一种超灵敏的免疫测定方法,可在纳米尺度上分辨和检测单个生物分子。本文重点介绍了单分子免疫测定技术的各种代表性技术和临床应用,同时还讨论了当前面临的挑战和未来的发展方向。通过技术和商业层面的多重优化,单分子免疫测定技术在实时检测、疾病诊断和治疗以及医学研究方面展现出了独特的优势。通过将个体化检测方法融入临床实践,这项技术有望为精准医疗的发展做出贡献。
{"title":"[Application of ultrasensitive single molecule immunoassay technology in clinical biomarker detection].","authors":"W C Jiang, G J Zhang","doi":"10.3760/cma.j.cn112150-20231212-00431","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20231212-00431","url":null,"abstract":"<p><p>Single-molecule immunoassay technology represents an ultrasensitive immunoassay method that enables the resolution and detection of individual biomolecules at the nanoscale. This article highlights various representative techniques and clinical applications of single-molecule immunoassay technology, while also discussing the current challenges and future development directions. Through multiple optimizations at both the technical and commercial levels, single-molecule immunoassay technology exhibits unique advantages in real-time detection, disease diagnosis and treatment, and medical research. This technology is poised to contribute to the advancement of precision medicine by integrating individualized detection methods into clinical practice.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983430","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Survey on the current situation of human resources of professional public health institutions in Weihai City from 2021 to 2023]. [2021-2023年威海市专业公共卫生机构人力资源现状调查]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240305-00186
K Wu, W H Wang, X Q Yu, Z H Yang

This study aims to promote the system construction of public health talent through understanding the status and identifying problems of public health human resources in Weihai City. A survey on professional public health institutions was conducted through questionnaires and interviews in Weihai City, and statistical analysis on the personnel structure, introduction, and turnover of professional public health institutions was conducted. There were 24 professional public health institutions in Weihai City, with a vacancy rate of 44.27% (1 367/3 088). Health professionals accounted for 68.09% (1 669/2 451) of the on-duty personnel. The number of health technicians in professional public health institutions in the city was 0.57 per thousand people. Among the 1 669 health professionals, the age groups≤35, 36-45, 46-54, and ≥55 accounted for 47.63% (795/1 669), 30.26% (505/1 669), 18.10% (302/1 669), and 4.01% (67/1 669), respectively. The personnel with bachelor's degrees and master's degrees accounted for 74.60% (1 245/1 669) and 8.09% (135/1 669). The personnel holding clinical medical, nursing, laboratory, and public health qualifications accounted for 61.34% (995/1 622), 28.30% (459/1 622) and 10.36% (168/1 622), respectively. Only 17.73% (296/1 669) of personnel held deputy senior or above technical titles, while 45.96% (767/1 669) held junior or below technical titles. About 70.10% (1 170/1 669) personnel held permanent positions, and 29.90% (499/1 669) held non-permanent positions. From 2021 to 2023, the employment rate of public health institutions was 65.51% (207/316), and the ratio of introduced and lost personnel was approximately 3∶2 (207/132).

本研究旨在通过了解威海市公共卫生人力资源现状、发现问题,促进公共卫生人才体系建设。通过问卷、访谈等方式对威海市专业公共卫生机构进行了调查,并对专业公共卫生机构人员结构、引进、流动等情况进行了统计分析。威海市共有 24 家专业公共卫生机构,空缺率为 44.27%(1 367/3 088)。在岗人员中,卫生专业技术人员占 68.09%(1 669/2 451)。全市专业公共卫生机构卫生技术人员数为 0.57 人/千人。在 1 669 名卫生技术人员中,年龄段≤35 岁、36-45 岁、46-54 岁、≥55 岁的分别占 47.63%(795/1 669)、30.26%(505/1 669)、18.10%(302/1 669)、4.01%(67/1 669)。拥有学士学位和硕士学位的人员分别占 74.60%(1 245/1 669)和 8.09%(135/1 669)。持有临床医学、护理、检验和公共卫生资格证书的人员分别占 61.34%(995/1 622)、28.30%(459/1 622)和 10.36%(168/1 622)。只有 17.73%(296/1 669)的人员具有副高级及以上技术职称,45.96%(767/1 669)的人员具有初级及以下技术职称。约 70.10%(1 170/1 669)的人员拥有长期职位,29.90%(499/1 669)的人员拥有非长期职位。2021 年至 2023 年,公共卫生机构就业率为 65.51%(207/316),引进与流失人员比例约为 3∶2(207/132)。
{"title":"[Survey on the current situation of human resources of professional public health institutions in Weihai City from 2021 to 2023].","authors":"K Wu, W H Wang, X Q Yu, Z H Yang","doi":"10.3760/cma.j.cn112150-20240305-00186","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240305-00186","url":null,"abstract":"<p><p>This study aims to promote the system construction of public health talent through understanding the status and identifying problems of public health human resources in Weihai City. A survey on professional public health institutions was conducted through questionnaires and interviews in Weihai City, and statistical analysis on the personnel structure, introduction, and turnover of professional public health institutions was conducted. There were 24 professional public health institutions in Weihai City, with a vacancy rate of 44.27% (1 367/3 088). Health professionals accounted for 68.09% (1 669/2 451) of the on-duty personnel. The number of health technicians in professional public health institutions in the city was 0.57 per thousand people. Among the 1 669 health professionals, the age groups≤35, 36-45, 46-54, and ≥55 accounted for 47.63% (795/1 669), 30.26% (505/1 669), 18.10% (302/1 669), and 4.01% (67/1 669), respectively. The personnel with bachelor's degrees and master's degrees accounted for 74.60% (1 245/1 669) and 8.09% (135/1 669). The personnel holding clinical medical, nursing, laboratory, and public health qualifications accounted for 61.34% (995/1 622), 28.30% (459/1 622) and 10.36% (168/1 622), respectively. Only 17.73% (296/1 669) of personnel held deputy senior or above technical titles, while 45.96% (767/1 669) held junior or below technical titles. About 70.10% (1 170/1 669) personnel held permanent positions, and 29.90% (499/1 669) held non-permanent positions. From 2021 to 2023, the employment rate of public health institutions was 65.51% (207/316), and the ratio of introduced and lost personnel was approximately 3∶2 (207/132).</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983452","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Epidemiological characteristics of human respiratory syncytial virus in influenza-like illness in Shenzhen City from 2019 to 2023]. [2019-2023年深圳市流感样病例中人呼吸道合胞病毒的流行病学特征]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240318-00223
Y Sun, W H Wu, Y L Huang, S S Fang, H Liu, M Jiang, J Meng, X Zou, X Wang

Objective: To understand the epidemiological characteristics of human respiratory syncytial virus (HRSV) among cases presenting with influenza-like illness (ILI) in Shenzhen City from 2019 to 2023. Methods: Respiratory specimens were collected from two national sentinel hospitals in Shenzhen from March 2019 to December 2023, specifically targeting cases of ILI. The real-time PCR method was used for the detection and genotyping of HRSV. Basic demographic information was collected and used for the epidemiological analysis. Results: A total of 9 278 respiratory specimens of influenza-like cases were collected and detected, with a total positive rate of 4.77% (443/9 278) for HRSV. In 2021 (8.48%, 167/1 970), the positive rate of HRSV was significantly higher than in 2019 (3.35%, 52/1 552), 2022 (1.80%, 39/2 169), and 2023 (4.49%, 133/2 960), and the difference was statistically significant (χ2=102.395, P<0.001). The prevalence of HRSV was mainly in summer and early autumn (September), and there was an abnormal increase in the positive rate of HRSV in winter 2022. The highest positive rate of HRSV was in children under five years old (9.84%, 330/335). The typing results showed that in 2022, the prevalence of HRSV-A was predominant (71.79%, 28/39), and in 2023, HRSV-A and HRSV-B subtypes coexisted. Conclusions: The prevalence of HRSV in Shenzhen from 2019 to 2023 has obvious seasonality, mainly in summer and early autumn. Children under five years old are the main population of HRSV infections.

目的了解2019-2023年深圳市流感样病例中人呼吸道合胞病毒(HRSV)的流行病学特征。研究方法收集2019年3月至2023年12月深圳市两家国家级哨点医院的呼吸道标本,主要针对ILI病例。采用实时 PCR 方法检测 HRSV 并进行基因分型。收集基本人口统计学信息并用于流行病学分析。研究结果共收集并检测了 9 278 份流感样病例的呼吸道标本,HRSV 阳性率为 4.77%(443/9 278)。2021年(8.48%,167/1 970)的HRSV阳性率明显高于2019年(3.35%,52/1 552)、2022年(1.80%,39/2 169)和2023年(4.49%,133/2 960),差异有统计学意义(χ2=102.395,PConclusions:2019-2023年深圳市HRSV流行具有明显的季节性,主要集中在夏季和初秋。5岁以下儿童是HRSV感染的主要人群。
{"title":"[Epidemiological characteristics of human respiratory syncytial virus in influenza-like illness in Shenzhen City from 2019 to 2023].","authors":"Y Sun, W H Wu, Y L Huang, S S Fang, H Liu, M Jiang, J Meng, X Zou, X Wang","doi":"10.3760/cma.j.cn112150-20240318-00223","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240318-00223","url":null,"abstract":"<p><p><b>Objective:</b> To understand the epidemiological characteristics of human respiratory syncytial virus (HRSV) among cases presenting with influenza-like illness (ILI) in Shenzhen City from 2019 to 2023. <b>Methods:</b> Respiratory specimens were collected from two national sentinel hospitals in Shenzhen from March 2019 to December 2023, specifically targeting cases of ILI. The real-time PCR method was used for the detection and genotyping of HRSV. Basic demographic information was collected and used for the epidemiological analysis. <b>Results:</b> A total of 9 278 respiratory specimens of influenza-like cases were collected and detected, with a total positive rate of 4.77% (443/9 278) for HRSV. In 2021 (8.48%, 167/1 970), the positive rate of HRSV was significantly higher than in 2019 (3.35%, 52/1 552), 2022 (1.80%, 39/2 169), and 2023 (4.49%, 133/2 960), and the difference was statistically significant (<i>χ<sup>2</sup></i>=102.395, <i>P</i><0.001). The prevalence of HRSV was mainly in summer and early autumn (September), and there was an abnormal increase in the positive rate of HRSV in winter 2022. The highest positive rate of HRSV was in children under five years old (9.84%, 330/335). The typing results showed that in 2022, the prevalence of HRSV-A was predominant (71.79%, 28/39), and in 2023, HRSV-A and HRSV-B subtypes coexisted. <b>Conclusions:</b> The prevalence of HRSV in Shenzhen from 2019 to 2023 has obvious seasonality, mainly in summer and early autumn. Children under five years old are the main population of HRSV infections.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983407","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Research progress on detection methods for human respiratory syncytial virus]. [人类呼吸道合胞病毒检测方法研究进展]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240108-00024
N Wang, H Li, J J Song, J H Song, Y Zhang

Human respiratory syncytial virus (HRSV) can infect individuals of all ages, with children under five years old, the elderly, and immunocompromised persons as the main high-risk groups. Although older children and adults often exhibit mild or no symptoms, they may still be potential carriers of the virus. Therefore, employing efficient, accurate, and rapid detection methods to timely identify infection sources and quickly halt transmission is an important means to curb the potential spread of the epidemic. However, the clinical manifestations of HRSV infection are difficult to distinguish from acute respiratory infections caused by other respiratory viruses, and the identification relies on the results of pathogen testing. This article summarizes four commonly used detection methods for HRSV based on detection principles: antigen detection, nucleic acid testing, antibody detection, and virus isolation. The advantages, disadvantages, principles, and applicable scenarios of these four methods are summarized and compared. Furthermore, the research progress and prospects of HRSV detection methods are reviewed.

人类呼吸道合胞病毒(HRSV)可感染所有年龄段的人,五岁以下儿童、老年人和免疫力低下者是主要的高危人群。虽然年长儿童和成年人通常表现出轻微或无症状,但他们仍可能是病毒的潜在携带者。因此,采用高效、准确、快速的检测方法,及时发现传染源并迅速阻止传播,是遏制疫情可能蔓延的重要手段。然而,HRSV 感染的临床表现很难与其他呼吸道病毒引起的急性呼吸道感染区分开来,其鉴别主要依赖于病原体检测的结果。本文根据检测原理总结了四种常用的 HRSV 检测方法:抗原检测、核酸检测、抗体检测和病毒分离。总结并比较了这四种方法的优缺点、原理和适用范围。此外,还综述了 HRSV 检测方法的研究进展和前景。
{"title":"[Research progress on detection methods for human respiratory syncytial virus].","authors":"N Wang, H Li, J J Song, J H Song, Y Zhang","doi":"10.3760/cma.j.cn112150-20240108-00024","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240108-00024","url":null,"abstract":"<p><p>Human respiratory syncytial virus (HRSV) can infect individuals of all ages, with children under five years old, the elderly, and immunocompromised persons as the main high-risk groups. Although older children and adults often exhibit mild or no symptoms, they may still be potential carriers of the virus. Therefore, employing efficient, accurate, and rapid detection methods to timely identify infection sources and quickly halt transmission is an important means to curb the potential spread of the epidemic. However, the clinical manifestations of HRSV infection are difficult to distinguish from acute respiratory infections caused by other respiratory viruses, and the identification relies on the results of pathogen testing. This article summarizes four commonly used detection methods for HRSV based on detection principles: antigen detection, nucleic acid testing, antibody detection, and virus isolation. The advantages, disadvantages, principles, and applicable scenarios of these four methods are summarized and compared. Furthermore, the research progress and prospects of HRSV detection methods are reviewed.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983413","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Component diagnosis of food allergy: precise identification of allergenic components in egg and milk]. [食物过敏的成分诊断:鸡蛋和牛奶中过敏成分的精确鉴定]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20240518-00401
H M Huang, A L Li, W T Luo, J L Zhang, B Q Sun

Food allergy are triggered by an abnormal immune response to specific food components, with milk and eggs being the most common food allergens, especially in children. Food allergy can cause various symptoms such as rashes, difficulty breathing, and digestive issues. Allergen component diagnostics is a technique used to identify specific allergenic proteins, aiding doctors in providing more precise treatment and management recommendations for patients. This article analyzes the latest research developments and clinical significance of milk and egg allergen components based on the " Molecular Allergology User's Guide 2.0 (MAUG 2.0)" issued by the European Academy of Allergy and Clinical Immunology (EAACI), including their applications in clinical diagnosis, treatment, and management. This article aims to enhance healthcare professionals' understanding of milk and egg allergies, offering new perspectives and practical guidelines for research and clinical practice to promote accurate diagnosis and personalized treatment strategies.

食物过敏是由对特定食物成分的异常免疫反应引发的,其中牛奶和鸡蛋是最常见的食物过敏原,尤其是对儿童而言。食物过敏会引起各种症状,如皮疹、呼吸困难和消化问题。过敏原成分诊断是一种用于识别特定过敏原蛋白的技术,有助于医生为患者提供更精确的治疗和管理建议。本文根据欧洲过敏与临床免疫学学会(EAACI)发布的《分子过敏学用户指南 2.0(MAUG 2.0)》,分析了牛奶和鸡蛋过敏原成分的最新研究进展和临床意义,包括其在临床诊断、治疗和管理中的应用。这篇文章旨在提高医护人员对牛奶和鸡蛋过敏的认识,为研究和临床实践提供新的视角和实用指南,以促进准确诊断和个性化治疗策略。
{"title":"[Component diagnosis of food allergy: precise identification of allergenic components in egg and milk].","authors":"H M Huang, A L Li, W T Luo, J L Zhang, B Q Sun","doi":"10.3760/cma.j.cn112150-20240518-00401","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20240518-00401","url":null,"abstract":"<p><p>Food allergy are triggered by an abnormal immune response to specific food components, with milk and eggs being the most common food allergens, especially in children. Food allergy can cause various symptoms such as rashes, difficulty breathing, and digestive issues. Allergen component diagnostics is a technique used to identify specific allergenic proteins, aiding doctors in providing more precise treatment and management recommendations for patients. This article analyzes the latest research developments and clinical significance of milk and egg allergen components based on the \" Molecular Allergology User's Guide 2.0 (MAUG 2.0)\" issued by the European Academy of Allergy and Clinical Immunology (EAACI), including their applications in clinical diagnosis, treatment, and management. This article aims to enhance healthcare professionals' understanding of milk and egg allergies, offering new perspectives and practical guidelines for research and clinical practice to promote accurate diagnosis and personalized treatment strategies.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Vaccine development based on RNA technology platforms]. [基于 RNA 技术平台的疫苗开发]。
Q3 Medicine Pub Date : 2024-08-06 DOI: 10.3760/cma.j.cn112150-20230831-00147
X Guo, J Li, H M Wang, J Qiu, Z Li, F Huang, J Li, X D Sun

mRNA vaccine technology has made significant progress in recent years, especially with the large-scale application driven by the COVID-19 pandemic. Moderna and Pfizer/BioNTech vaccines have become central tools in the global fight against the virus, demonstrating the potential of the mRNA platform for rapid design, production, and strong immune responses. These vaccines showcase the unique advantages of rapid response and effective protection. At the same time, mRNA technology still faces challenges, such as stability and targeted delivery. Future research will focus on improving the stability and safety of mRNA vaccine and expanding its application to more infectious diseases and cancer treatments. This article reviews platforms of mRNA vaccine, vaccine design, development of delivery system, and the application of mRNA vaccines, in order to enhance the understanding of professionals and accelerate the layout of this technology in vaccine research and application in China.

mRNA 疫苗技术近年来取得了重大进展,尤其是在 COVID-19 大流行的推动下得到了大规模应用。Moderna 和辉瑞/BioNTech 公司的疫苗已成为全球抗击病毒的核心工具,展示了 mRNA 平台在快速设计、生产和强大免疫反应方面的潜力。这些疫苗展示了快速反应和有效保护的独特优势。与此同时,mRNA 技术仍然面临着稳定性和定向递送等挑战。未来的研究重点是提高 mRNA 疫苗的稳定性和安全性,并将其应用扩展到更多的传染病和癌症治疗领域。本文对mRNA疫苗的平台、疫苗设计、递送系统的开发以及mRNA疫苗的应用进行了综述,以期加深专业人士对mRNA疫苗的了解,加快该技术在中国疫苗研究和应用领域的布局。
{"title":"[Vaccine development based on RNA technology platforms].","authors":"X Guo, J Li, H M Wang, J Qiu, Z Li, F Huang, J Li, X D Sun","doi":"10.3760/cma.j.cn112150-20230831-00147","DOIUrl":"https://doi.org/10.3760/cma.j.cn112150-20230831-00147","url":null,"abstract":"<p><p>mRNA vaccine technology has made significant progress in recent years, especially with the large-scale application driven by the COVID-19 pandemic. Moderna and Pfizer/BioNTech vaccines have become central tools in the global fight against the virus, demonstrating the potential of the mRNA platform for rapid design, production, and strong immune responses. These vaccines showcase the unique advantages of rapid response and effective protection. At the same time, mRNA technology still faces challenges, such as stability and targeted delivery. Future research will focus on improving the stability and safety of mRNA vaccine and expanding its application to more infectious diseases and cancer treatments. This article reviews platforms of mRNA vaccine, vaccine design, development of delivery system, and the application of mRNA vaccines, in order to enhance the understanding of professionals and accelerate the layout of this technology in vaccine research and application in China.</p>","PeriodicalId":24033,"journal":{"name":"中华预防医学杂志","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2024-08-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141983455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中华预防医学杂志
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1